As someone who has been writing about stocks professionally for 18 years, I remember when Microsoft (NASDAQ: MSFT ), Amazon (NASDAQ: AMZN ) and Apple (NASDAQ: AAPL ) were the first companies with $1 t
Former FDA Commissioner and Pfizer Board Member Dr. Scott Gottlieb joins 'The Exchange' to discuss the Surgeon General's social media warning, new weight loss drugs coming to market, and the potential
The Baron Health Care Fund's first five years have been exceptional in every sense of the word. Launched in spring 2018, the fund has navigated around the COVID-19 pandemic, a biotech initial public o

The 3 Best Momentum Stocks to Buy in May 2023

09:05am, Monday, 22'nd May 2023
Momentum stocks are securities that are rising fast and seeing their gains accelerate. This is often because a given stock has one or more catalysts that have led to a rally in its share price.
Biogen and Eli Lilly both have promising Alzheimer's drugs that have shown they are effective in slowing the rate of cognitive decline in patients. They both come with risks related to brain swelling
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Big pharmaceutical stocks, including Novartis AG NYSE: NVS, Eli Lilly & Co. NYSE: LLY, Merck & Co. NYSE: MRK, and Novo Nordisk A/S NYSE: NVO have been outperforming the broader market recently, even a
Everyone seems to be talking about semiconductors, artificial intelligence (AI) and mega-cap tech. However, no one seems to be talking about healthcare stocks to buy.
If Eli Lilly stays around 440, this calendar spread profits on its neutral outlook. The post Eli Lilly Stock Doesn't Have To Shoot Higher For Profits appeared first on Investor's Business Daily.
Eli Lilly's new obesity drug could be a gamechanger, both for those who take it and for Lilly stock.
CNBC's Jim Cramer is looking to 2011 for investing guidance during the ongoing debt ceiling uncertainty.
Lilly's Alzheimer's treatment could reach blockbuster status by 2025, an analyst said Monday. Eli Lilly stock is trading near a record high.
Lilly (LLY) expects to launch four new medicines by 2023 end, of which Mounjaro for type II diabetes and cancer drug Jaypirca have already been launched.
The Regional Bank Fiasco is a classic “Baby with the Bathwater” scenario. Rising rates are great for Insurance companies and “hidden banks”.
Eli Lilly and Company (NYSE:LLY ) Bank of America Securities 2023 Healthcare Conference May 10, 2023 1:00 PM ET Company Participants Patrik Jonsson - Executive Vice President, President-Lilly Immunolo
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE